APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide Antibiotics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Peptide Antibiotics Industry Growth and Trends Forecast to 2032

26 December 2025103 pages

Choose your research edition.

Industry ResearchPeptide Antibiotics Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Antibiotics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Peptide Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Antibiotics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Antibiotics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Peptide Antibiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peptide Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peptide Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peptide Antibiotics include AMP Therapeutics, Hospira, Kasten, Madam Therapeutics, Pacgen Life Science Corporation, Phosphagenics, Savara Pharmaceuticals, Theravance and Vicuron Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peptide Antibiotics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peptide Antibiotics market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptide Antibiotics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptide Antibiotics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Peptide Antibiotics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peptide Antibiotics Market by Company

AMP Therapeutics

Hospira

Kasten

Madam Therapeutics

Pacgen Life Science Corporation

Phosphagenics

Savara Pharmaceuticals

Theravance

Vicuron Pharmaceuticals

GlaxoSmithKline

Pfizer

Eli Lilly

Novartis

Peptide Antibiotics Segment by Type

Ribosomal Synthesized Peptide Antibiotics

Non-Ribosomally Synthesized Peptide Antibiotics

Peptide Antibiotics Segment by Application

Pharma & Healthcare

Food Industry

Commodities

Other

Peptide Antibiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Antibiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptide Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Peptide Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ribosomal Synthesized Peptide Antibiotics Table 2. Major Company of Non-Ribosomally Synthesized Peptide Antibiotics Table 3. Global Peptide Antibiotics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Peptide Antibiotics Sales by Type (2021-2026) & (Tons) Table 5. Global Peptide Antibiotics Sales Market Share in Volume by Type (2021-2026) Table 6. Global Peptide Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 7. Global Peptide Antibiotics Sales Market Share in Value by Type (2021-2026) Table 8. Global Peptide Antibiotics Price by Type (2021-2026) & (US$/Ton) Table 9. Global Peptide Antibiotics Sales by Type (2027-2032) & (Tons) Table 10. Global Peptide Antibiotics Sales Market Share in Volume by Type (2027-2032) Table 11. Global Peptide Antibiotics Sales by Type (2027-2032) & (US$ Million) Table 12. Global Peptide Antibiotics Sales Market Share in Value by Type (2027-2032) Table 13. Global Peptide Antibiotics Price by Type (2027-2032) & (US$/Ton) Table 14. North America Peptide Antibiotics Sales by Type (2021-2026) & (Tons) Table 15. North America Peptide Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Peptide Antibiotics Sales by Type (2021-2026) & (Tons) Table 17. Europe Peptide Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Peptide Antibiotics Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Peptide Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Peptide Antibiotics Sales by Type (2021-2026) & (Tons) Table 21. Latin America Peptide Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Peptide Antibiotics Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Peptide Antibiotics Sales by Type (2021-2026) & (US$ Million) Table 24. Peptide Antibiotics Industry Trends Table 25. Peptide Antibiotics Industry Drivers Table 26. Peptide Antibiotics Industry Opportunities and Challenges Table 27. Peptide Antibiotics Industry Restraints Table 28. Global Peptide Antibiotics Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Peptide Antibiotics Revenue Market Share by Company (2021-2026) Table 30. Global Peptide Antibiotics Sales by Company (2021-2026) & (Tons) Table 31. Global Peptide Antibiotics Sales Share by Company (2021-2026) Table 32. Global Peptide Antibiotics Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Peptide Antibiotics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Peptide Antibiotics Major Company Production Sites and Headquarters Table 35. Global Peptide Antibiotics Company, Product Type & Application Table 36. Global Peptide Antibiotics Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Peptide Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Peptide Antibiotics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Peptide Antibiotics Sales by Region (2021-2026) & (Tons) Table 41. Global Peptide Antibiotics Sales Market Share in Volume by Region (2021-2026) Table 42. Global Peptide Antibiotics Sales by Region (2021-2026) & (US$ Million) Table 43. Global Peptide Antibiotics Sales Market Share in Value by Region (2021-2026) Table 44. Global Peptide Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Peptide Antibiotics Sales by Region (2027-2032) & (Tons) Table 46. Global Peptide Antibiotics Sales Market Share in Volume by Region (2027-2032) Table 47. Global Peptide Antibiotics Sales by Region (2027-2032) & (US$ Million) Table 48. Global Peptide Antibiotics Sales Market Share in Value by Region (2027-2032) Table 49. Global Peptide Antibiotics Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Peptide Antibiotics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Peptide Antibiotics Sales by Application (2021-2026) & (Tons) Table 52. Global Peptide Antibiotics Sales Market Share in Volume by Application (2021-2026) Table 53. Global Peptide Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 54. Global Peptide Antibiotics Sales Market Share in Value by Application (2021-2026) Table 55. Global Peptide Antibiotics Price by Application (2021-2026) & (US$/Ton) Table 56. Global Peptide Antibiotics Sales by Application (2027-2032) & (Tons) Table 57. Global Peptide Antibiotics Sales Market Share in Volume by Application (2027-2032) Table 58. Global Peptide Antibiotics Sales by Application (2027-2032) & (US$ Million) Table 59. Global Peptide Antibiotics Sales Market Share in Value by Application (2027-2032) Table 60. Global Peptide Antibiotics Price by Application (2027-2032) & (US$/Ton) Table 61. North America Peptide Antibiotics Sales by Application (2021-2026) & (Tons) Table 62. North America Peptide Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Peptide Antibiotics Sales by Application (2021-2026) & (Tons) Table 64. Europe Peptide Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Peptide Antibiotics Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Peptide Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Peptide Antibiotics Sales by Application (2021-2026) & (Tons) Table 68. Latin America Peptide Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Peptide Antibiotics Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Peptide Antibiotics Sales by Application (2021-2026) & (US$ Million) Table 71. AMP Therapeutics Company Information Table 72. AMP Therapeutics Business Overview Table 73. AMP Therapeutics Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. AMP Therapeutics Peptide Antibiotics Product Portfolio Table 75. AMP Therapeutics Recent Development Table 76. Hospira Company Information Table 77. Hospira Business Overview Table 78. Hospira Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Hospira Peptide Antibiotics Product Portfolio Table 80. Hospira Recent Development Table 81. Kasten Company Information Table 82. Kasten Business Overview Table 83. Kasten Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Kasten Peptide Antibiotics Product Portfolio Table 85. Kasten Recent Development Table 86. Madam Therapeutics Company Information Table 87. Madam Therapeutics Business Overview Table 88. Madam Therapeutics Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Madam Therapeutics Peptide Antibiotics Product Portfolio Table 90. Madam Therapeutics Recent Development Table 91. Pacgen Life Science Corporation Company Information Table 92. Pacgen Life Science Corporation Business Overview Table 93. Pacgen Life Science Corporation Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Pacgen Life Science Corporation Peptide Antibiotics Product Portfolio Table 95. Pacgen Life Science Corporation Recent Development Table 96. Phosphagenics Company Information Table 97. Phosphagenics Business Overview Table 98. Phosphagenics Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Phosphagenics Peptide Antibiotics Product Portfolio Table 100. Phosphagenics Recent Development Table 101. Savara Pharmaceuticals Company Information Table 102. Savara Pharmaceuticals Business Overview Table 103. Savara Pharmaceuticals Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Savara Pharmaceuticals Peptide Antibiotics Product Portfolio Table 105. Savara Pharmaceuticals Recent Development Table 106. Theravance Company Information Table 107. Theravance Business Overview Table 108. Theravance Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Theravance Peptide Antibiotics Product Portfolio Table 110. Theravance Recent Development Table 111. Vicuron Pharmaceuticals Company Information Table 112. Vicuron Pharmaceuticals Business Overview Table 113. Vicuron Pharmaceuticals Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Vicuron Pharmaceuticals Peptide Antibiotics Product Portfolio Table 115. Vicuron Pharmaceuticals Recent Development Table 116. GlaxoSmithKline Company Information Table 117. GlaxoSmithKline Business Overview Table 118. GlaxoSmithKline Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. GlaxoSmithKline Peptide Antibiotics Product Portfolio Table 120. GlaxoSmithKline Recent Development Table 121. Pfizer Company Information Table 122. Pfizer Business Overview Table 123. Pfizer Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Pfizer Peptide Antibiotics Product Portfolio Table 125. Pfizer Recent Development Table 126. Eli Lilly Company Information Table 127. Eli Lilly Business Overview Table 128. Eli Lilly Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. Eli Lilly Peptide Antibiotics Product Portfolio Table 130. Eli Lilly Recent Development Table 131. Novartis Company Information Table 132. Novartis Business Overview Table 133. Novartis Peptide Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 134. Novartis Peptide Antibiotics Product Portfolio Table 135. Novartis Recent Development Table 136. North America Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 137. North America Peptide Antibiotics Sales by Country (2021-2026) & (Tons) Table 138. North America Peptide Antibiotics Sales Market Share by Country (2021-2026) Table 139. North America Peptide Antibiotics Sales Forecast by Country (2027-2032) & (Tons) Table 140. North America Peptide Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 141. North America Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Peptide Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Peptide Antibiotics Market Share by Country (2021-2026) Table 144. North America Peptide Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Peptide Antibiotics Market Share Forecast by Country (2027-2032) Table 146. Europe Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 147. Europe Peptide Antibiotics Sales by Country (2021-2026) & (Tons) Table 148. Europe Peptide Antibiotics Sales Market Share by Country (2021-2026) Table 149. Europe Peptide Antibiotics Sales Forecast by Country (2027-2032) & (Tons) Table 150. Europe Peptide Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Peptide Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Peptide Antibiotics Market Share by Country (2021-2026) Table 154. Europe Peptide Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Peptide Antibiotics Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Peptide Antibiotics Sales by Country (2021-2026) & (Tons) Table 158. Asia-Pacific Peptide Antibiotics Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Peptide Antibiotics Sales Forecast by Country (2027-2032) & (Tons) Table 160. Asia-Pacific Peptide Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Peptide Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Peptide Antibiotics Market Share by Country (2021-2026) Table 164. Asia-Pacific Peptide Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Peptide Antibiotics Market Share Forecast by Country (2027-2032) Table 166. Latin America Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 167. Latin America Peptide Antibiotics Sales by Country (2021-2026) & (Tons) Table 168. Latin America Peptide Antibiotics Sales Market Share by Country (2021-2026) Table 169. Latin America Peptide Antibiotics Sales Forecast by Country (2027-2032) & (Tons) Table 170. Latin America Peptide Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Peptide Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Peptide Antibiotics Market Share by Country (2021-2026) Table 174. Latin America Peptide Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Peptide Antibiotics Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Peptide Antibiotics Sales by Country (2021-2026) & (Tons) Table 178. Middle East and Africa Peptide Antibiotics Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Peptide Antibiotics Sales Forecast by Country (2027-2032) & (Tons) Table 180. Middle East and Africa Peptide Antibiotics Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Peptide Antibiotics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Peptide Antibiotics Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Peptide Antibiotics Market Share by Country (2021-2026) Table 184. Middle East and Africa Peptide Antibiotics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Peptide Antibiotics Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Peptide Antibiotics Distributors List Table 189. Peptide Antibiotics Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Peptide Antibiotics Image Figure 2. Global Peptide Antibiotics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peptide Antibiotics Market Size (2021-2032) & (US$ Million) Figure 4. Global Peptide Antibiotics Sales (2021-2032) & (Tons) Figure 5. Ribosomal Synthesized Peptide Antibiotics Image Figure 6. Global Ribosomal Synthesized Peptide Antibiotics Sales YoY Growth (2021-2032) & (Tons) Figure 7. Non-Ribosomally Synthesized Peptide Antibiotics Image Figure 8. Global Non-Ribosomally Synthesized Peptide Antibiotics Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Peptide Antibiotics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Peptide Antibiotics Market Share by Type 2025 VS 2032 Figure 11. North America Peptide Antibiotics Sales Market Share in Volume by Type in 2025 Figure 12. North America Peptide Antibiotics Sales Market Share in Value by Type in 2025 Figure 13. Europe Peptide Antibiotics Sales Market Share in Volume by Type in 2025 Figure 14. Europe Peptide Antibiotics Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Peptide Antibiotics Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Peptide Antibiotics Sales Market Share in Value by Type in 2025 Figure 17. Latin America Peptide Antibiotics Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Peptide Antibiotics Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Peptide Antibiotics Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Peptide Antibiotics Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Peptide Antibiotics Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharma & Healthcare Image Figure 24. Global Pharma & Healthcare Sales YoY Growth (2021-2032) & (Tons) Figure 25. Food Industry Image Figure 26. Global Food Industry Sales YoY Growth (2021-2032) & (Tons) Figure 27. Commodities Image Figure 28. Global Commodities Sales YoY Growth (2021-2032) & (Tons) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Peptide Antibiotics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Peptide Antibiotics Market Share by Application 2025 VS 2032 Figure 33. North America Peptide Antibiotics Sales Market Share in Volume by Application in 2025 Figure 34. North America Peptide Antibiotics Sales Market Share in Value by Application in 2025 Figure 35. Europe Peptide Antibiotics Sales Market Share in Volume by Application in 2025 Figure 36. Europe Peptide Antibiotics Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Peptide Antibiotics Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Peptide Antibiotics Sales Market Share in Value by Application in 2025 Figure 39. Latin America Peptide Antibiotics Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Peptide Antibiotics Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Peptide Antibiotics Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Peptide Antibiotics Sales Market Share in Value by Application in 2025 Figure 43. North America Peptide Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Peptide Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Peptide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Peptide Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Peptide Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Peptide Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Peptide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Peptide Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Peptide Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Peptide Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Peptide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Peptide Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Peptide Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Peptide Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Peptide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Peptide Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Peptide Antibiotics Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Peptide Antibiotics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Peptide Antibiotics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Peptide Antibiotics Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Peptide Antibiotics Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Peptide Antibiotics Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Ribosomal Synthesized Peptide Antibiotics
  • Non-Ribosomally Synthesized Peptide Antibiotics
Applications
  • Pharma & Healthcare
  • Food Industry
  • Commodities
  • Other
Companies covered
  • AMP Therapeutics
  • Hospira
  • Kasten
  • Madam Therapeutics
  • Pacgen Life Science Corporation
  • Phosphagenics
  • Savara Pharmaceuticals
  • Theravance
  • Vicuron Pharmaceuticals
  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peptide Antibiotics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Peptide Antibiotics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Peptide Antibiotics Market by Type
  6. 1.3.1 Ribosomal Synthesized Peptide Antibiotics
  7. 1.3.2 Non-Ribosomally Synthesized Peptide Antibiotics
  8. 1.4 Global Peptide Antibiotics Market Size by Type
  9. 1.4.1 Global Peptide Antibiotics Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Peptide Antibiotics Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Peptide Antibiotics Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Peptide Antibiotics Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Peptide Antibiotics Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Peptide Antibiotics Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Peptide Antibiotics Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Peptide Antibiotics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Peptide Antibiotics Industry Trends
  2. 2.2 Peptide Antibiotics Industry Drivers
  3. 2.3 Peptide Antibiotics Industry Opportunities and Challenges
  4. 2.4 Peptide Antibiotics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Peptide Antibiotics Revenue (2021-2026)
  2. 3.2 Global Top Players by Peptide Antibiotics Sales (2021-2026)
  3. 3.3 Global Top Players by Peptide Antibiotics Price (2021-2026)
  4. 3.4 Global Peptide Antibiotics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Peptide Antibiotics Major Company Production Sites & Headquarters
  6. 3.6 Global Peptide Antibiotics Company, Product Type & Application
  7. 3.7 Global Peptide Antibiotics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Peptide Antibiotics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Peptide Antibiotics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Peptide Antibiotics Tier 1, Tier 2, and Tier 3
4 Peptide Antibiotics Regional Status and Outlook
  1. 4.1 Global Peptide Antibiotics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Peptide Antibiotics Historic Market Size by Region
  3. 4.2.1 Global Peptide Antibiotics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Peptide Antibiotics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Peptide Antibiotics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Peptide Antibiotics Forecasted Market Size by Region
  7. 4.3.1 Global Peptide Antibiotics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Peptide Antibiotics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Peptide Antibiotics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Peptide Antibiotics by Application
  1. 5.1 Peptide Antibiotics Market by Application
  2. 5.1.1 Pharma & Healthcare
  3. 5.1.2 Food Industry
  4. 5.1.3 Commodities
  5. 5.1.4 Other
  6. 5.2 Global Peptide Antibiotics Market Size by Application
  7. 5.2.1 Global Peptide Antibiotics Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Peptide Antibiotics Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Peptide Antibiotics Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Peptide Antibiotics Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Peptide Antibiotics Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Peptide Antibiotics Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Peptide Antibiotics Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Peptide Antibiotics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AMP Therapeutics
  2. 6.1.1 AMP Therapeutics Company Information
  3. 6.1.2 AMP Therapeutics Business Overview
  4. 6.1.3 AMP Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AMP Therapeutics Peptide Antibiotics Product Portfolio
  6. 6.1.5 AMP Therapeutics Recent Developments
  7. 6.2 Hospira
  8. 6.2.1 Hospira Company Information
  9. 6.2.2 Hospira Business Overview
  10. 6.2.3 Hospira Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hospira Peptide Antibiotics Product Portfolio
  12. 6.2.5 Hospira Recent Developments
  13. 6.3 Kasten
  14. 6.3.1 Kasten Company Information
  15. 6.3.2 Kasten Business Overview
  16. 6.3.3 Kasten Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Kasten Peptide Antibiotics Product Portfolio
  18. 6.3.5 Kasten Recent Developments
  19. 6.4 Madam Therapeutics
  20. 6.4.1 Madam Therapeutics Company Information
  21. 6.4.2 Madam Therapeutics Business Overview
  22. 6.4.3 Madam Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Madam Therapeutics Peptide Antibiotics Product Portfolio
  24. 6.4.5 Madam Therapeutics Recent Developments
  25. 6.5 Pacgen Life Science Corporation
  26. 6.5.1 Pacgen Life Science Corporation Company Information
  27. 6.5.2 Pacgen Life Science Corporation Business Overview
  28. 6.5.3 Pacgen Life Science Corporation Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pacgen Life Science Corporation Peptide Antibiotics Product Portfolio
  30. 6.5.5 Pacgen Life Science Corporation Recent Developments
  31. 6.6 Phosphagenics
  32. 6.6.1 Phosphagenics Company Information
  33. 6.6.2 Phosphagenics Business Overview
  34. 6.6.3 Phosphagenics Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Phosphagenics Peptide Antibiotics Product Portfolio
  36. 6.6.5 Phosphagenics Recent Developments
  37. 6.7 Savara Pharmaceuticals
  38. 6.7.1 Savara Pharmaceuticals Company Information
  39. 6.7.2 Savara Pharmaceuticals Business Overview
  40. 6.7.3 Savara Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Savara Pharmaceuticals Peptide Antibiotics Product Portfolio
  42. 6.7.5 Savara Pharmaceuticals Recent Developments
  43. 6.8 Theravance
  44. 6.8.1 Theravance Company Information
  45. 6.8.2 Theravance Business Overview
  46. 6.8.3 Theravance Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Theravance Peptide Antibiotics Product Portfolio
  48. 6.8.5 Theravance Recent Developments
  49. 6.9 Vicuron Pharmaceuticals
  50. 6.9.1 Vicuron Pharmaceuticals Company Information
  51. 6.9.2 Vicuron Pharmaceuticals Business Overview
  52. 6.9.3 Vicuron Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Vicuron Pharmaceuticals Peptide Antibiotics Product Portfolio
  54. 6.9.5 Vicuron Pharmaceuticals Recent Developments
  55. 6.10 GlaxoSmithKline
  56. 6.10.1 GlaxoSmithKline Company Information
  57. 6.10.2 GlaxoSmithKline Business Overview
  58. 6.10.3 GlaxoSmithKline Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GlaxoSmithKline Peptide Antibiotics Product Portfolio
  60. 6.10.5 GlaxoSmithKline Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Peptide Antibiotics Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Eli Lilly
  68. 6.12.1 Eli Lilly Company Information
  69. 6.12.2 Eli Lilly Business Overview
  70. 6.12.3 Eli Lilly Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Eli Lilly Peptide Antibiotics Product Portfolio
  72. 6.12.5 Eli Lilly Recent Developments
  73. 6.13 Novartis
  74. 6.13.1 Novartis Company Information
  75. 6.13.2 Novartis Business Overview
  76. 6.13.3 Novartis Peptide Antibiotics Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Novartis Peptide Antibiotics Product Portfolio
  78. 6.13.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Peptide Antibiotics Sales by Country
  2. 7.1.1 North America Peptide Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Peptide Antibiotics Sales by Country (2021-2026)
  4. 7.1.3 North America Peptide Antibiotics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Peptide Antibiotics Market Size by Country
  6. 7.2.1 North America Peptide Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Peptide Antibiotics Market Size by Country (2021-2026)
  8. 7.2.3 North America Peptide Antibiotics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Peptide Antibiotics Sales by Country
  2. 8.1.1 Europe Peptide Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Peptide Antibiotics Sales by Country (2021-2026)
  4. 8.1.3 Europe Peptide Antibiotics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Peptide Antibiotics Market Size by Country
  6. 8.2.1 Europe Peptide Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Peptide Antibiotics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Peptide Antibiotics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Peptide Antibiotics Sales by Country
  2. 9.1.1 Asia-Pacific Peptide Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Peptide Antibiotics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Peptide Antibiotics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Peptide Antibiotics Market Size by Country
  6. 9.2.1 Asia-Pacific Peptide Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Peptide Antibiotics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Peptide Antibiotics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Peptide Antibiotics Sales by Country
  2. 10.1.1 South America Peptide Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Peptide Antibiotics Sales by Country (2021-2026)
  4. 10.1.3 South America Peptide Antibiotics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Peptide Antibiotics Market Size by Country
  6. 10.2.1 South America Peptide Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Peptide Antibiotics Market Size by Country (2021-2026)
  8. 10.2.3 South America Peptide Antibiotics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Peptide Antibiotics Sales by Country
  2. 11.1.1 Middle East and Africa Peptide Antibiotics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Peptide Antibiotics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Peptide Antibiotics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Peptide Antibiotics Market Size by Country
  6. 11.2.1 Middle East and Africa Peptide Antibiotics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Peptide Antibiotics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Peptide Antibiotics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Peptide Antibiotics Value Chain Analysis
  2. 12.1.1 Peptide Antibiotics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Peptide Antibiotics Production Mode & Process
  7. 12.2 Peptide Antibiotics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Peptide Antibiotics Distributors
  10. 12.2.3 Peptide Antibiotics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst